A new education initiative aims to expand awareness of DBS and empower people with Parkinson’s to make informed decisions ...

The Michael J. Fox Foundation provides info on stem cell clinical trials for Parkinson’s and how to find available studies ...

Five takeaways on progress altering the Parkinson’s therapeutic landscape, from day two of The Michael J. Fox Foundation’s ...

The U.S. Food and Drug Administration (FDA) has approved tavapadon, a once-daily oral medication for the treatment of motor symptoms of Parkinson’s disease. Tavapadon, which will be sold under the ...

NEW YORK, NY – July 13, 2026 – The Alzheimer’s Drug Discovery Foundation’s (ADDF) Diagnostics Accelerator (DxA) and The Michael J. Fox Foundation (MJFF) today announced a new $5 million partnership to ...

Editor’s note: On Tuesday, May 26, 2026, Vermont Governor Phil Scott signed H. 739 into law, making Vermont first in the United States to ban paraquat, a pesticide linked to increased Parkinson’s ...

NEW YORK, May 5, 2026 /PRNewswire/ — The Michael J. Fox Foundation for Parkinson’s Research (MJFF), which sponsors the landmark Parkinson’s Progression Markers Initiative (PPMI), today announced the ...

This March, the 2026 Parkinson’s Policy Forum brought more than 300 advocates from 49 states to Washington, D.C. to deliver a unified message to Congress: people living with Parkinson’s and their ...

A new report released on March 26, 2026, by The Michael J. Fox Foundation (MJFF) shows that the annual economic impact of Parkinson’s disease and atypical parkinsonisms in the United States reached ...

“One of the things I’m most happy about, with all the things I’ve done over the past 25 years, is helping take the shame out of having Parkinson’s. There used to be a lot of shame, for whatever reason ...

For people living with Parkinson’s disease — and for the families, friends and care partners who love them — progress depends not only on scientific discovery but also the public policies that help ...